Biotech

Breaking news and analysis on the biotech industry — covering drug development, clinical trials, IPOs, M&A, and the companies pushing biopharma forward.

Biotech

ESMO: Roche touts ‘convincing’ KRAS data after phase 3 win

Roche has shed more light on its investigational KRAS G12C inhibitor’s phase 3 victory over Amgen’s Lumakras and Bristol Myers Squibb’s Krazati.

James Waldron Oct 25, 2026 11:30am

ESMO: AZ exec insists ph. 3 ADC data ‘robust’ despite PFS miss

Oct 25, 2026 11:30am

How AI is reshaping biopharma decision-making

Brought to you by Clarivate

ESMO: J&J's RIPTAC is ‘best data we’ve seen’ for prostate cancer

Oct 25, 2026 9:45am

Biotech value creation at an inflection point

Brought to you by Lumanity

ESMO: Merck exec unruffled by ‘unfortunate’ cancer vax data leak

Oct 24, 2026 6:24am